Chris Smith has a diverse work experience in the field of investment and business development. Chris started their career at CSL in 2009 as a Manager of New Product Opportunities and later became a Business Development Manager. In 2012, they joined Brandon Capital, where they held various roles including Investment Manager, Senior Investment Manager, and Investment Director. Chris also served as a Director for multiple companies including Denteric Pty Ltd, Paragen Bio, Okogen Inc., MecRx Pty Ltd, Aravax, Ena Therapeutics Pty Ltd, Q-Sera, and Solvanix.
Chris Smith earned a Bachelor of Science (B.Sc.) degree in Microbiology and Immunology from the University of Melbourne, which they attended from 1995 to 2005. Following this, they pursued a Doctor of Philosophy (PhD) in Immunology at the Walter and Eliza Hall Institute from 2001 to 2005. Later, in 2007-2008, they completed an MBA degree in Business at the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices